Publications

1. Lauria M, Stiehl B, Santhanam A, O'Connell D, Naumann L, McNitt-Gray M, Raldow A, Goldin J, Barjaktarevic I, Low DA. An analysis of the regional heterogeneity in tissue elasticity in lung cancer patients with COPD.. Frontiers in medicine, 2023.
2. Riou C, du Bruyn E, Kim GHJ, da Costa I, Lee J, Sher A, Wilkinson RJ, Allwood BW, Goldin J. Derivation of a high-resolution CT-based, semi-automated radiographic score in tuberculosis and its relationship to bacillary load and antitubercular therapy.. The European respiratory journal, 2023.
3. Azour L, Goldin JG, Kruskal JB. Radiologist and Radiology Practice Wellbeing: A Report of the 2023 ARRS Wellness Summit.. Academic radiology, 2023.
4. Gong AJ, Ruchalski K, Kim HJ, Douek M, Gutierrez A, Patel M, Sai V, Coy H, Villegas B, Raman S, Goldin J. RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment.. Radiology. Imaging cancer, 2023.
5. Volkmann ER, Wilhalme H, Assassi S, Kim GHJ, Goldin J, Kuwana M, Tashkin DP, Roth MD. Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy.. ACR open rheumatology, 2023.
6. Novogrodsky E, Haramati LB, Villasana-Gomez GM, Goldman J, Rosenfeld C, Rosenblum JK, Sayre JW, Hoyt AC, Goldin JG, Milch HS. Lung Cancer Screening Among Mammography Patients: Knowledge, Eligibility, Participation, and Interest.. Journal of the American Board of Family Medicine : JABFM, 2023.
7. Choi Y, Yu W, Nagarajan MB, Teng P, Goldin JG, Raman SS, Enzmann DR, Kim GHJ, Brown MS. Translating AI to Clinical Practice: Overcoming Data Shift with Explainability.. Radiographics : a review publication of the Radiological Society of North America, Inc, 2023.
8. Wong KP, Homer SY, Wei SH, Yaghmai N, Estrada Paz OA, Young TJ, Buhr RG, Barjaktarevic I, Shrestha L, Daly M, Goldin J, Enzmann DR, Brown MS. Integration and evaluation of chest X-ray artificial intelligence in clinical practice.. Journal of medical imaging (Bellingham, Wash.), 2023.
9. Dolinay T, Jun D, Maller A, Chung A, Grimes B, Hsu L, Nelson D, Villagas B, Kim GHJ, Goldin J. Quantitative image analysis in COVID-19 acute respiratory distress syndrome: a cohort observational study.. F1000Research, 2023.
10. Yeo J, Yoon SH, Kim JY, Lee JS, Lee EY, Goo JM, Pourzand L, Goldin JG, Kim GJ, Ha YJ. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications.. Rheumatology (Oxford, England), 2023.
11. Volkmann ER, Tashkin DP, Leng M, Kim GHJ, Goldin J, Roth MD. Association of Symptoms of Gastroesophageal Reflux, Esophageal Dilation, and Progression of Systemic Sclerosis-Related Interstitial Lung Disease.. Arthritis care & research, 2023.
12. Hsia CCW, Bates JHT, Driehuys B, Fain SB, Goldin JG, Hoffman EA, Hogg JC, Levin DL, Lynch DA, Ochs M, Parraga G, Prisk GK, Smith BM, Tawhai M, Vidal Melo MF, Woods JC, Hopkins SR. Quantitative Imaging Metrics for the Assessment of Pulmonary Pathophysiology: An Official American Thoracic Society and Fleischner Society Joint Workshop Report.. Annals of the American Thoracic Society, 2023.
13. Yu W, Zhou H, Choi Y, Goldin JG, Teng P, Wong WK, McNitt-Gray MF, Brown MS, Kim GHJ. Multi-scale, domain knowledge-guided attention + random forest: a two-stage deep learning-based multi-scale guided attention models to diagnose idiopathic pulmonary fibrosis from computed tomography images.. Medical physics, 2022.
14. Volkmann ER, Tashkin DP, Silver R, Bostwick CF, Assassi S, Frost DB, Leng M, Wilhalme H, Kim GH, Goldin J, Roth MD. Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials.. The Lancet. Rheumatology, 2022.
15. Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.. Neuro-oncology, 2022.
16. Ruchalski K, Kim HJ, Douek M, Raman S, Patel M, Sai V, Gutierrez A, Levine B, Fischer C, Allen-Auerbach M, Gupta P, Coy H, Villegas B, Brown M, Goldin J. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.. Cancer imaging : the official publication of the International Cancer Imaging Society, 2022.
17. Brogan P, Naden R, Ardoin SP, Cooper JC, De Benedetti F, Dicaire JF, Eleftheriou D, Feldman B, Goldin J, Karol SE, Price-Kuehne F, Skuse D, Stratakis CA, Webb N, Stone JH. The pediatric glucocorticoid toxicity index.. Seminars in arthritis and rheumatism, 2022.
18. Brown MS, Wong KP, Shrestha L, Wahi-Anwar M, Daly M, Foster G, Abtin F, Ruchalski KL, Goldin JG, Enzmann D. Automated Endotracheal Tube Placement Check Using Semantically Embedded Deep Neural Networks.. Academic radiology, 2022.
19. Weigt SS, Kim GJ, Jones HD, Ramsey AL, Amubieya O, Abtin F, Pourzand L, Lee J, Shino MY, DerHovanessian A, Stripp B, Noble PW, Sayah DM, Saggar R, Britton I, Lynch JP, Belperio JA, Goldin J. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.. Transplantation, 2022.
20. Ellingson BM, Kim GHJ, Brown M, Lee J, Salamon N, Steelman L, Hassan I, Pandya SS, Chun S, Linetsky M, Yoo B, Wen PY, Mellinghoff IK, Goldin J, Cloughesy TF. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.. Neuro-oncology, 2022.
21. Khanna D, Lin CJF, Furst DE, Wagner B, Zucchetto M, Raghu G, Martinez FJ, Goldin J, Siegel J, Denton CP. Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.. American journal of respiratory and critical care medicine, 2022.
22. Singh D, Wild JM, Saralaya D, Lawson R, Marshall H, Goldin J, Brown MS, Kostikas K, Belmore K, Fogel R, Patalano F, Drollmann A, Machineni S, Jones I, Yates D, Tillmann HC. Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.. Respiratory research, 2022.
23. Khanna D, Distler O, Cottin V, Brown KK, Chung L, Goldin JG, Matteson EL, Kazerooni EA, Walsh SL, McNitt-Gray M, Maher TM. Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.. Journal of scleroderma and related disorders, 2022.
24. Volkmann ER, Tashkin DP, Roth MD, Goldin J, Kim GHJ. Early Radiographic Progression of Scleroderma: Lung Disease Predicts Long-term Mortality.. Chest, 2021.
25. Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).. BMJ open respiratory research, 2021.
26. Bae SS, Pourzand L, Hyun Kim G, Villegas BE, Oh A, Furst DE, Goldin J, Tashkin DP. The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort.. Journal of scleroderma and related disorders, 2021.
27. Low DA, O'Connell D, Lauria M, Stiehl B, Naumann L, Lee P, Hegde J, Barjaktarevic I, Goldin J, Santhanam A. Ventilation measurements using fast-helical free-breathing computed tomography.. Medical physics, 2021.
28. Lee JS, Kim GJ, Ha YJ, Kang EH, Lee YJ, Goldin JG, Lee EY. The Extent and Diverse Trajectories of Longitudinal Changes in Rheumatoid Arthritis Interstitial Lung Diseases Using Quantitative HRCT Scores.. Journal of clinical medicine, 2021.
29. Stiehl B, Lauria M, Singhrao K, Goldin J, Barjaktarevic I, Low D, Santhanam A. Scalable quorum-based deep neural networks with adversarial learning for automated lung lobe segmentation in fast helical free-breathing CTs.. International journal of computer assisted radiology and surgery, 2021.
30. Lauria M, Singhrao K, Stiehl B, Low D, Goldin J, Barjaktarevic I, Santhanam A. Automatic triangulated mesh generation of pulmonary airways from segmented lung 3DCTs for computational fluid dynamics.. International journal of computer assisted radiology and surgery, 2021.
31. Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, de Andrade JA, Johannson KA, Kolb MR, Lynch DA, Oldham JM, Spagnolo P, Strek ME, Tomassetti S, Washko GR, White ES, ILA Study Group. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.. Chest, 2021.
32. Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, Huang S, Khanna D, focuSSced Investigators. Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.. Arthritis & rheumatology (Hoboken, N.J.), 2021.
33. Ruchalski K, Braschi-Amirfarzan M, Douek M, Sai V, Gutierrez A, Dewan R, Goldin J. A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials.. Radiology. Imaging cancer, 2021.
34. Assassi S, Li N, Volkmann ER, Mayes MD, Rünger D, Ying J, Roth MD, Hinchcliff M, Khanna D, Frech T, Clements PJ, Furst DE, Goldin J, Bernstein EJ, Castelino FV, Domsic RT, Gordon JK, Hant FN, Shah AA, Shanmugam VK, Steen VD, Elashoff RM, Tashkin DP. Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease.. Arthritis & rheumatology (Hoboken, N.J.), 2021.
35. Yu W, Zhou H, Goldin JG, Wong WK, Kim GHJ. End-to-end domain knowledge-assisted automatic diagnosis of idiopathic pulmonary fibrosis (IPF) using computed tomography (CT).. Medical physics, 2021.
36. Bellocchi C, Ying J, Goldmuntz EA, Keyes-Elstein L, Varga J, Hinchcliff ME, Lyons MA, McSweeney P, Furst DE, Nash R, Crofford LJ, Welch B, Goldin JG, Pinckney A, Mayes MD, Sullivan KM, Assassi S. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.. Arthritis & rheumatology (Hoboken, N.J.), 2021.
37. Ellingson BM, Brown MS, Boxerman JL, Gerstner ER, Kaufmann TJ, Cole PE, Bacha JA, Leung D, Barone A, Colman H, van den Bent MJ, Wen PY, Alfred Yung WK, Cloughesy TF, Goldin JG. Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.. Neuro-oncology, 2021.
38. Goldin JG. The Emerging Role of Quantification of Imaging for Assessing the Severity and Disease Activity of Emphysema, Airway Disease, and Interstitial Lung Disease.. Respiration; international review of thoracic diseases, 2021.
39. Kim GHJ, Goldin JG, Hayes W, Oh A, Soule B, Du S. The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.. Therapeutic advances in respiratory disease, 2021.
40. Santhanam AP, Stiehl B, Lauria M, Hasse K, Barjaktarevic I, Goldin J, Low DA. An adversarial machine learning framework and biomechanical model-guided approach for computing 3D lung tissue elasticity from end-expiration 3DCT.. Medical physics, 2020.
41. Volkmann ER, Steen V, Li N, Roth MD, Clements PJ, Furst DE, Assassi S, Khanna D, Kim GJ, Goldin J, Elashoff RM, Tashkin DP. Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and II.. ACR open rheumatology, 2020.
42. Lancaster L, Goldin J, Trampisch M, Kim GH, Ilowite J, Homik L, Hotchkin DL, Kaye M, Ryerson CJ, Mogulkoc N, Conoscenti CS. Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis.. The open respiratory medicine journal, 2020.
43. Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP, focuSSced investigators. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.. The Lancet. Respiratory medicine, 2020.
44. Volkmann ER, Tashkin DP, Roth MD, Li N, Charles J, Mayes M, Kim G, Goldin J, Pourzand L, Clements PJ, Furst DE, Khanna D, Elashoff RM, Assassi S. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis.. Seminars in arthritis and rheumatism, 2020.
45. Volkmann ER, Tashkin DP, LeClair H, Roth MD, Kim G, Goldin J, Clements PJ, Furst DE, Khanna D. Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II.. ACR open rheumatology, 2020.
46. Allwood BW, Maasdorp E, Kim GJ, Cooper CB, Goldin J, van Zyl-Smit RN, Bateman ED, Dawson R. Transition from Restrictive to Obstructive Lung Function Impairment During Treatment and Follow-Up of Active Tuberculosis.. International journal of chronic obstructive pulmonary disease, 2020.
47. Rubin GD, Ryerson CJ, Haramati LB, Sverzellati N, Kanne JP, Raoof S, Schluger NW, Volpi A, Yim JJ, Martin IBK, Anderson DJ, Kong C, Altes T, Bush A, Desai SR, Goldin J, Goo JM, Humbert M, Inoue Y, Kauczor HU, Luo F, Mazzone PJ, Prokop M, Remy-Jardin M, Richeldi L, Schaefer-Prokop CM, Tomiyama N, Wells AU, Leung AN. The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society.. Chest, 2020.
48. Wang X, Teng P, Ontiveros A, Goldin JG, Brown MS. High throughput image labeling on chest computed tomography by deep learning.. Journal of medical imaging (Bellingham, Wash.), 2020.
49. Brown MS, Lo P, Goldin JG, Barnoy E, Kim GHJ, McNitt-Gray MF, Aberle DR. Correction to: Toward clinically usable CAD for lung cancer screening with computed tomography.. European radiology, 2020.
50. Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease.. Arthritis & rheumatology (Hoboken, N.J.), 2019.
51. Volkmann ER, Tashkin DP, Kuwana M, Li N, Roth MD, Charles J, Hant FN, Bogatkevich GS, Akter T, Kim G, Goldin J, Khanna D, Clements PJ, Furst DE, Elashoff RM, Silver RM, Assassi S. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18.. Arthritis & rheumatology (Hoboken, N.J.), 2019.
52. Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial.. The Lancet. Respiratory medicine, 2019.
53. Shi Y, Wong WK, Goldin JG, Brown MS, Kim GHJ. Prediction of progression in idiopathic pulmonary fibrosis using CT scans at baseline: A quantum particle swarm optimization - Random forest approach.. Artificial intelligence in medicine, 2019.
54. Kim GHJ, Weigt SS, Belperio JA, Brown MS, Shi Y, Lai JH, Goldin JG. Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups.. European radiology, 2019.
55. Coy HJ, Douek ML, Ruchalski K, Kim HJ, Gutierrez A, Patel M, Sai V, Margolis DJA, Kaplan A, Brown M, Goldin J, Raman SS. Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma.. Radiology, 2019.
56. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM. Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II.. The Journal of rheumatology, 2019.
57. Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis.. American journal of respiratory and critical care medicine, 2019.
58. Volkmann ER, Tashkin DP, Sim M, Kim GH, Goldin J, Clements PJ. Determining progression of scleroderma-related interstitial lung disease.. Journal of scleroderma and related disorders, 2018.
59. Goldin JG, Kim GHJ, Tseng CH, Volkmann E, Furst D, Clements P, Brown M, Roth M, Khanna D, Tashkin DP. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.. Annals of the American Thoracic Society, 2018.
60. Goldin JG. Predicting Outcome in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomography Analysis.. American journal of respiratory and critical care medicine, 2018.
61. Nagarajan MB, Raman SS, Lo P, Lin WC, Khoshnoodi P, Sayre JW, Ramakrishna B, Ahuja P, Huang J, Margolis DJA, Lu DSK, Reiter RE, Goldin JG, Brown MS, Enzmann DR. Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.. Abdominal radiology (New York), 2018.
62. Chung JH, Goldin JG. Interpretation of HRCT Scans in the Diagnosis of IPF: Improving Communication Between Pulmonologists and Radiologists.. Lung, 2018.
63. Brown M, Browning P, Wahi-Anwar MW, Murphy M, Delgado J, Greenspan H, Abtin F, Ghahremani S, Yaghmai N, da Costa I, Becker M, Goldin J. Integration of Chest CT CAD into the Clinical Workflow and Impact on Radiologist Efficiency.. Academic radiology, 2018.
64. Brown MS, Kim GHJ, Chu GH, Ramakrishna B, Allen-Auerbach M, Fischer CP, Levine B, Gupta PK, Schiepers CW, Goldin JG. Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer.. Journal of medical imaging (Bellingham, Wash.), 2018.
65. Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.. The New England journal of medicine, 2018.
66. Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.. The Lancet. Respiratory medicine, 2017.
67. Martyanov V, Kim GJ, Hayes W, Du S, Ganguly BJ, Sy O, Lee SK, Bogatkevich GS, Schieven GL, Schiopu E, Marangoni RG, Goldin J, Whitfield ML, Varga J. Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.. PloS one, 2017.
68. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D. Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).. American journal of respiratory and critical care medicine, 2017.
69. Khanna D, Seibold J, Goldin J, Tashkin DP, Furst DE, Wells A. Interstitial lung disease points to consider for clinical trials in systemic sclerosis.. Rheumatology (Oxford, England), 2017.
70. Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.. Arthritis & rheumatology (Hoboken, N.J.), 2017.
71. van Zyl-Smit RN, Esmail A, Bateman ME, Dawson R, Goldin J, van Rikxoort E, Douoguih M, Pau MG, Sadoff JC, McClain JB, Snowden MA, Benko J, Hokey DA, Rutkowski KT, Graves A, Shepherd B, Ishmukhamedov S, Kagina BMN, Abel B, Hanekom WA, Scriba TJ, Bateman ED. Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.. American journal of respiratory and critical care medicine, 2017.
72. Allwood BW, Gillespie R, Galperin-Aizenberg M, Bateman M, Olckers H, Taborda-Barata L, Calligaro GL, Said-Hartley Q, Van Zyl-Smit R, Cooper CB, Van Rikxoort E, Goldin J, Beyers N, Bateman ED. Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort.. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2017.
73. Young S, Lo P, Kim G, Brown M, Hoffman J, Hsu W, Wahi-Anwar W, Flores C, Lee G, Noo F, Goldin J, McNitt-Gray M. The effect of radiation dose reduction on computer-aided detection (CAD) performance in a low-dose lung cancer screening population.. Medical physics, 2017.
74. Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.. Chest, 2016.
75. Tashkin DP, Kim HJ, Zeidler M, Kleerup E, Goldin J. Evaluating small-airways disease in asthmatic patients: The utility of quantitative computed tomography.. The Journal of allergy and clinical immunology, 2016.
76. Sieren JP, Newell JD, Barr RG, Bleecker ER, Burnette N, Carretta EE, Couper D, Goldin J, Guo J, Han MK, Hansel NN, Kanner RE, Kazerooni EA, Martinez FJ, Rennard S, Woodruff PG, Hoffman EA, SPIROMICS Research Group. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs.. American journal of respiratory and critical care medicine, 2016.
77. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study II Investigators. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.. The Lancet. Respiratory medicine, 2016.
78. Raghu G, Scholand MB, de Andrade J, Lancaster L, Mageto Y, Goldin J, Brown KK, Flaherty KR, Wencel M, Wanger J, Neff T, Valone F, Stauffer J, Porter S. FG-3019 anti-connective tissue growth factor monoclonal antibody: results of an open-label clinical trial in idiopathic pulmonary fibrosis.. The European respiratory journal, 2016.
79. Argula RG, Kokosi M, Lo P, Kim HJ, Ravenel JG, Meyer C, Goldin J, Lee HS, Strange C, McCormack FX, MILES Study Investigators. A Novel Quantitative Computed Tomographic Analysis Suggests How Sirolimus Stabilizes Progressive Air Trapping in Lymphangioleiomyomatosis.. Annals of the American Thoracic Society, 2016.
80. Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.. Annals of the rheumatic diseases, 2016.
81. Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin DP, Goldin J. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.. Arthritis research & therapy, 2015.
82. Chong DY, Kim HJ, Lo P, Young S, McNitt-Gray MF, Abtin F, Goldin JG, Brown MS. Robustness-Driven Feature Selection in Classification of Fibrotic Interstitial Lung Disease Patterns in Computed Tomography Using 3D Texture Features.. IEEE transactions on medical imaging, 2015.
83. Hansell DM, Goldin JG, King TE, Lynch DA, Richeldi L, Wells AU. CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society.. The Lancet. Respiratory medicine, 2015.
84. Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.. Annals of the rheumatic diseases, 2014.
85. Kim HJ, Brown MS, Chong D, Gjertson DW, Lu P, Kim HJ, Coy H, Goldin JG. Comparison of the quantitative CT imaging biomarkers of idiopathic pulmonary fibrosis at baseline and early change with an interval of 7 months.. Academic radiology, 2014.
86. Brown MS, Lo P, Goldin JG, Barnoy E, Kim GH, McNitt-Gray MF, Aberle DR. Toward clinically usable CAD for lung cancer screening with computed tomography.. European radiology, 2014.
87. Gompelmann D, Eberhardt R, Slebos DJ, Brown MS, Abtin F, Kim HJ, Holmes-Higgin D, Radhakrishnan S, Herth FJ, Goldin J. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction.. Respirology (Carlton, Vic.), 2014.
88. Saggar R, Khanna D, Vaidya A, Derhovanessian A, Maranian P, Duffy E, Belperio JA, Weigt SS, Dua S, Shapiro SS, Goldin JG, Abtin F, Lynch JP, Ross DJ, Forfia PR, Saggar R. Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.. Thorax, 2014.
89. Chu G, Lo P, Ramakrishna B, Kim H, Morris D, Goldin J, Brown M. Bone tumor segmentation on bone scans using context information and random forests.. Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2014.
90. Argula RG, Strange C, Ramakrishnan V, Goldin J. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema.. Chest, 2013.
91. Goldin JG. Computed tomography as a biomarker in clinical trials imaging.. Journal of thoracic imaging, 2013.
92. Huo J, Okada K, van Rikxoort EM, Kim HJ, Alger JR, Pope WB, Goldin JG, Brown MS. Ensemble segmentation for GBM brain tumors on MR images using confidence-based averaging.. Medical physics, 2013.
93. Valipour A, Herth FJ, Burghuber OC, Criner G, Vergnon JM, Goldin J, Sciurba F, Ernst A, VENT Study Group. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy.. The European respiratory journal, 2013.
94. Lee RJ, Saylor PJ, Michaelson MD, Rothenberg SM, Smas ME, Miyamoto DT, Gurski CA, Xie W, Maheswaran S, Haber DA, Goldin JG, Smith MR. A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases.. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013.
95. Brown MS, Chu GH, Kim HJ, Allen-Auerbach M, Poon C, Bridges J, Vidovic A, Ramakrishna B, Ho J, Morris MJ, Larson SM, Scher HI, Goldin JG. Computer-aided quantitative bone scan assessment of prostate cancer treatment response.. Nuclear medicine communications, 2012.
96. Brown MS, Kim HJ, Abtin FG, Strange C, Galperin-Aizenberg M, Pais R, Da Costa IG, Ordookhani A, Chong D, Ni C, McNitt-Gray MF, Tashkin DP, Goldin JG. Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes.. European radiology, 2012.
97. COPDGene CT Workshop Group, Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edula G, Erikkson L, Friedlander A, Galperin-Aizenberg M, Gefter WB, Gierada DS, Grenier PA, Goldin J, Han MK, Hanania NA, Hansel NN, Jacobson FL, Kauczor HU, Kinnula VL, Lipson DA, Lynch DA, MacNee W, Make BJ, Mamary AJ, Mann H, Marchetti N, Mascalchi M, McLennan G, Murphy JR, Naidich D, Nath H, Newell JD, Pistolesi M, Regan EA, Reilly JJ, Sandhaus R, Schroeder JD, Sciurba F, Shaker S, Sharafkhaneh A, Silverman EK, Steiner RM, Strange C, Sverzellati N, Tashjian JH, van Beek EJ, Washington L, Washko GR, Westney G, Wood SA, Woodruff PG. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation.. COPD, 2012.
98. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.. Journal of neuro-oncology, 2012.
99. Chong D, Brown MS, Kim HJ, van Rikxoort EM, Guzman L, McNitt-Gray MF, Khatonabadi M, Galperin-Aizenberg M, Coy H, Yang K, Jung Y, Goldin JG. Reproducibility of volume and densitometric measures of emphysema on repeat computed tomography with an interval of 1 week.. European radiology, 2011.
100. van Rikxoort EM, Goldin JG, Galperin-Aizenberg M, Abtin F, Kim HJ, Lu P, van Ginneken B, Shaw G, Brown MS. A method for the automatic quantification of the completeness of pulmonary fissures: evaluation in a database of subjects with severe emphysema.. European radiology, 2011.
101. Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin DP. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.. Arthritis and rheumatism, 2011.
102. Kim HJ, Brown MS, Elashoff R, Li G, Gjertson DW, Lynch DA, Strollo DC, Kleerup E, Chong D, Shah SK, Ahmad S, Abtin F, Tashkin DP, Goldin JG. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.. European radiology, 2011.
103. Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM, Scleroderma Lung Study Research Group. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.. Arthritis and rheumatism, 2011.
104. Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.. Clinical trials (London, England), 2011.
105. National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The National Lung Screening Trial: overview and study design.. Radiology, 2010.
106. Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, McLennan G, VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema.. The New England journal of medicine, 2010.
107. Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, Seibold JR, Silver RM, Tashkin DP, Wells AU. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.. Clinical and experimental rheumatology, 2010.
108. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD.. American journal of respiratory and critical care medicine, 2010.
109. Strollo D, Goldin J. Imaging lung disease in systemic sclerosis.. Current rheumatology reports, 2010.
110. Hansell DM, Boiselle PM, Goldin J, Kauczor HU, Lynch DA, Mayo JR, Patz EF. Thoracic imaging.. Respirology (Carlton, Vic.), 2010.
111. Brown MS, Kim HJ, Abtin F, Da Costa I, Pais R, Ahmad S, Angel E, Ni C, Kleerup EC, Gjertson DW, McNitt-Gray MF, Goldin JG. Reproducibility of lung and lobar volume measurements using computed tomography.. Academic radiology, 2009.
112. Schindler TH, Cadenas J, Facta AD, Li Y, Olschewski M, Sayre J, Goldin J, Schelbert HR. Improvement in coronary endothelial function is independently associated with a slowed progression of coronary artery calcification in type 2 diabetes mellitus.. European heart journal, 2009.
113. D'Armiento JM, Scharf SM, Roth MD, Connett JE, Ghio A, Sternberg D, Goldin JG, Louis TA, Mao JT, O'Connor GT, Ramsdell JW, Ries AL, Schluger NW, Sciurba FC, Skeans MA, Voelker H, Walter RE, Wendt CH, Weinmann GG, Wise RA, Foronjy RF. Eosinophil and T cell markers predict functional decline in COPD patients.. Respiratory research, 2009.
114. Angel E, Yaghmai N, Jude CM, DeMarco JJ, Cagnon CH, Goldin JG, McCollough CH, Primak AN, Cody DD, Stevens DM, McNitt-Gray MF. Dose to radiosensitive organs during routine chest CT: effects of tube current modulation.. AJR. American journal of roentgenology, 2009.
115. Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin DP. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.. Chest, 2009.
116. Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone.. Journal of neuro-oncology, 2009.
117. Itagaki MW, Suh RD, Goldin JG. Cardiac CT research: exponential growth.. Radiology, 2009.
118. Goldin JG. Imaging the lungs in patients with pulmonary emphysema.. Journal of thoracic imaging, 2009.
119. Pope WB, Kim HJ, Huo J, Alger J, Brown MS, Gjertson D, Sai V, Young JR, Tekchandani L, Cloughesy T, Mischel PS, Lai A, Nghiemphu P, Rahmanuddin S, Goldin J. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.. Radiology, 2009.
120. Goldin JG, Abtin F. Update on radiology of emphysema and therapeutic implications.. Thoracic surgery clinics, 2009.
121. Lee EW, Suh RD, Zeidler MR, Tsai IS, Cameron RB, Abtin FG, Goldin JG. Radiofrequency ablation of subpleural lung malignancy: reduced pain using an artificially created pneumothorax.. Cardiovascular and interventional radiology, 2009.
122. Ochs RA, Abtin F, Ghurabi R, Rao A, Ahmad S, Brown M, Goldin JG. Computer-aided detection of endobronchial valves using volumetric CT.. Academic radiology, 2009.
123. Angel E, Yaghmai N, Jude CM, Demarco JJ, Cagnon CH, Goldin JG, Primak AN, Stevens DM, Cody DD, McCollough CH, McNitt-Gray MF. Monte Carlo simulations to assess the effects of tube current modulation on breast dose for multidetector CT.. Physics in medicine and biology, 2009.
124. Ochs RA, Petkovska I, Kim HJ, Abtin F, Brown M, Goldin J. Prevalence of tracheal collapse in an emphysema cohort as measured with end-expiration CT.. Academic radiology, 2009.
125. Prasad MN, Brown MS, Ahmad S, Abtin F, Allen J, da Costa I, Kim HJ, McNitt-Gray MF, Goldin JG. Automatic segmentation of lung parenchyma in the presence of diseases based on curvature of ribs.. Academic radiology, 2008.
126. Schindler TH, Facta AD, Prior JO, Cadenas J, Zhang XL, Li Y, Sayre J, Goldin J, Schelbert HR. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.. European journal of nuclear medicine and molecular imaging, 2008.
127. Kim HJ, Li G, Gjertson D, Elashoff R, Shah SK, Ochs R, Vasunilashorn F, Abtin F, Brown MS, Goldin JG. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study.. Academic radiology, 2008.
128. Prasad MN, Brown MS, Ni C, Margolis DJ, Douek M, Raman S, Lu D, Goldin J. Three-dimensional mapping of gallbladder wall thickness on computed tomography using Laplace's equation.. Academic radiology, 2008.
129. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research Group. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease.. Chest, 2008.
130. Goldin JG, Brown MS, Petkovska I. Computer-aided diagnosis in lung nodule assessment.. Journal of thoracic imaging, 2008.
131. Brown ER, Kronmal RA, Bluemke DA, Guerci AD, Carr JJ, Goldin J, Detrano R. Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi-Ethnic Study of Atherosclerosis.. Radiology, 2008.
132. Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Research Group. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.. American journal of respiratory and critical care medicine, 2007.
133. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G, Scleroderma Lung Study Research Group. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.. American journal of respiratory and critical care medicine, 2007.
134. Strange C, Herth FJ, Kovitz KL, McLennan G, Ernst A, Goldin J, Noppen M, Criner GJ, Sciurba FC, VENT Study Group. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction.. BMC pulmonary medicine, 2007.
135. Krishnam MS, Suh RD, Tomasian A, Goldin JG, Lai C, Brown K, Batra P, Aberle DR. Postoperative complications of lung transplantation: radiologic findings along a time continuum.. Radiographics : a review publication of the Radiological Society of North America, Inc, 2007.
136. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, Lynch JP, Ardehali A, Goldin J. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.. Chest, 2007.
137. Brown MS, Pais R, Qing P, Shah S, McNitt-Gray MF, Goldin JG, Petkovska I, Tran L, Aberle DR. An architecture for computer-aided detection and radiologic measurement of lung nodules in clinical trials.. Cancer informatics, 2007.
138. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, Sterz M, Seibold JR, Schraufnagel D, Simms RW, Bolster M, Wise RA, Steen V, Mayes MD, Connelly K, Metersky M, Furst DE, Scleroderma Lung Study Group. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.. Annals of the rheumatic diseases, 2007.
139. Brown MS, McNitt-Gray MF, Pais R, Shah SK, Qing P, Da Costa I, Aberle DR, Goldin JG. CAD in clinical trials: current role and architectural requirements.. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2007.
140. Petkovska I, Brown MS, Goldin JG, Kim HJ, McNitt-Gray MF, Abtin FG, Ghurabi RJ, Aberle DR. The effect of lung volume on nodule size on CT.. Academic radiology, 2007.
141. Ochs RA, Goldin JG, Abtin F, Kim HJ, Brown K, Batra P, Roback D, McNitt-Gray MF, Brown MS. Automated classification of lung bronchovascular anatomy in CT using AdaBoost.. Medical image analysis, 2007.
142. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C. Accuracy of PET/CT in characterization of solitary pulmonary lesions.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007.
143. Suh RD, Goldin JG. High-resolution computed tomography of interstitial pulmonary fibrosis.. Seminars in respiratory and critical care medicine, 2006.
144. Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, Louis TA, Mao JT, Muindi JR, O'Connor GT, Ramsdell JW, Ries AL, Scharf SM, Schluger NW, Sciurba FC, Skeans MA, Walter RE, Wendt CH, Wise RA, FORTE Study Investigators. Feasibility of retinoids for the treatment of emphysema study.. Chest, 2006.
145. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, Guerci AD, Lima JA, Rader DJ, Rubin GD, Shaw LJ, Wiegers SE, American Heart Association Committee on Cardiovascular Imaging and Intervention, American Heart Association Council on Cardiovascular Radiology and Intervention, American Heart Association Committee on Cardiac Imaging, Council on Clinical Cardiology. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.. Circulation, 2006.
146. Zeidler MR, Goldin JG, Kleerup EC, Kim HJ, Truong DA, Gjertson DW, Kennedy NJ, Newman KB, Tashkin DP, Silverman JM, Corren J. Small airways response to naturalistic cat allergen exposure in subjects with asthma.. The Journal of allergy and clinical immunology, 2006.
147. Pham PH, Rao DS, Vasunilashorn F, Fishbein MC, Goldin JG. Computed tomography calcium quantification as a measure of atherosclerotic plaque morphology and stability.. Investigative radiology, 2006.
148. Nael K, Michaely HJ, Lee M, Goldin J, Laub G, Finn JP. Dynamic pulmonary perfusion and flow quantification with MR imaging, 3.0T vs. 1.5T: initial results.. Journal of magnetic resonance imaging : JMRI, 2006.
149. Nael K, Michaely HJ, Kramer U, Lee MH, Goldin J, Laub G, Finn JP. Pulmonary circulation: contrast-enhanced 3.0-T MR angiography--initial results.. Radiology, 2006.
150. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group. Cyclophosphamide versus placebo in scleroderma lung disease.. The New England journal of medicine, 2006.
151. Petkovska I, Shah SK, McNitt-Gray MF, Goldin JG, Brown MS, Kim HJ, Brown K, Aberle DR. Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps.. European journal of radiology, 2006.
152. Rao DS, Goldin JG, Fishbein MC. Determinants of plaque instability in atherosclerotic vascular disease.. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 2005.
153. Shah SK, McNitt-Gray MF, Rogers SR, Goldin JG, Suh RD, Sayre JW, Petkovska I, Kim HJ, Aberle DR. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features.. Academic radiology, 2005.
154. Brody AS, Tiddens HA, Castile RG, Coxson HO, de Jong PA, Goldin J, Huda W, Long FR, McNitt-Gray M, Rock M, Robinson TE, Sagel SD, CT Scanning in Cystic Fibrosis Special Interest Group. Computed tomography in the evaluation of cystic fibrosis lung disease.. American journal of respiratory and critical care medicine, 2005.
155. Brown MS, Goldin JG, Rogers S, Kim HJ, Suh RD, McNitt-Gray MF, Shah SK, Truong D, Brown K, Sayre JW, Gjertson DW, Batra P, Aberle DR. Computer-aided lung nodule detection in CT: results of large-scale observer test.. Academic radiology, 2005.
156. Shah SK, McNitt-Gray MF, Rogers SR, Goldin JG, Suh RD, Sayre JW, Petkovska I, Kim HJ, Aberle DR. Computer-aided diagnosis of the solitary pulmonary nodule.. Academic radiology, 2005.
157. Nelson JC, Kronmal RA, Carr JJ, McNitt-Gray MF, Wong ND, Loria CM, Goldin JG, Williams OD, Detrano R. Measuring coronary calcium on CT images adjusted for attenuation differences.. Radiology, 2005.
158. Shah SK, McNitt-Gray MF, De Zoysa KR, Sayre JW, Kim HJ, Batra P, Behrashi A, Brown K, Greaser LE, Park JM, Roback DK, Wu C, Zaragoza E, Goldin JG, Suh RD, Brown MS, Aberle DR. Solitary pulmonary nodule diagnosis on CT: results of an observer study.. Academic radiology, 2005.
159. Brown MS, Shah SK, Pais RC, Lee YZ, McNitt-Gray MF, Goldin JG, Cardenas AF, Aberle DR. Database design and implementation for quantitative image analysis research.. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society, 2005.
160. Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, Gjertson D, Rogers SR, Aberle DR. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.. Academic radiology, 2004.
161. Goldin JG. Quantitative CT of emphysema and the airways.. Journal of thoracic imaging, 2004.
162. Boedeker KL, McNitt-Gray MF, Rogers SR, Truong DA, Brown MS, Gjertson DW, Goldin JG. Emphysema: effect of reconstruction algorithm on CT imaging measures.. Radiology, 2004.
163. Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin DP, Roth MD. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.. Arthritis and rheumatism, 2004.
164. Suh RD, Goldin JG, Wallace AB, Sheehan RE, Heinze SB, Gitlitz BJ, Figlin RA. Metastatic renal cell carcinoma: CT-guided immunotherapy as a technically feasible and safe approach to delivery of gene therapy for treatment.. Radiology, 2004.
165. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.. Radiology, 2003.
166. Steckel RJ, Batra P, Goldin JG, Zucker M, Sayre JW, Johnson SL. Supervision of residents by faculty radiologists using home workstations.. Emergency radiology, 2003.
167. Lima EM, Goodman WG, Kuizon BD, Gales B, Emerick A, Goldin J, Salusky IB. Bone density measurements in pediatric patients with renal osteodystrophy.. Pediatric nephrology (Berlin, Germany), 2003.
168. Brown MS, Goldin JG, Suh RD, McNitt-Gray MF, Sayre JW, Aberle DR. Lung micronodules: automated method for detection at thin-section CT--initial experience.. Radiology, 2003.
169. Hill JA, Goldin JG, Gjertson D, Emerick AM, Greaser LD, Yoon HC, Khorrami S, Aziz D, Adams JS. Progression of coronary artery calcification in patients taking alendronate for osteoporosis.. Academic radiology, 2002.
170. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects.. Radiology, 2002.
171. Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin DP, Roth MD. A pilot study of all-trans-retinoic acid for the treatment of human emphysema.. American journal of respiratory and critical care medicine, 2002.
172. Goldin JG. Quantitative CT of the lung.. Radiologic clinics of North America, 2002.